Cargando…

Real-world incidence and prevalence of systemic lupus erythematosus in Alberta, Canada

Systemic lupus erythematosus (SLE) is rather uncommon than rare. The purpose of this study was to estimate the incidence and prevalence of SLE in the population of Alberta, Canada, using administrative health data. Multiple population-based data sources, including the Alberta Health Care Insurance P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fatoye, Francis, Gebrye, Tadesse, Svenson, Lawrence W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105153/ https://www.ncbi.nlm.nih.gov/pubmed/29987494 http://dx.doi.org/10.1007/s00296-018-4091-4

Ejemplares similares

Direct health system costs for systemic lupus erythematosus patients in Alberta, Canada
por: Fatoye, Francis, et al.
Publicado: (2021)

Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysis
por: Fatoye, Francis, et al.
Publicado: (2022)

Burden of musculoskeletal-related disorders resulting from non-fatal road traffic collisions in Africa: a protocol of a systematic review
por: Yusuf, Mohamed, et al.
Publicado: (2019)

A scoping review on quality assessment tools used in systematic reviews and meta-analysis of real-world studies
por: Gebrye, Tadesse, et al.
Publicado: (2023)

The incidence and prevalence of systemic lupus erythematosus in the UK, 1999–2012
por: Rees, Frances, et al.
Publicado: (2016)

Cancer incidence and mortality among the Métis population of Alberta, Canada
por: Sanchez-Ramirez, Diana C., et al.
Publicado: (2016)

Assessing the impact of COVID-19 pandemic on the health of residents and the healthcare system in Alberta, Canada: an observational study—The Alberta POST-COVID Follow-up Study
por: Chen, Xueyi, et al.
Publicado: (2023)

Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review
por: Fatoye, F, et al.
Publicado: (2019)

Cohort profile: systemic lupus erythematosus in Sweden: the Swedish Lupus Linkage (SLINK) cohort
por: Arkema, Elizabeth V, et al.
Publicado: (2015)

Developments in asthma incidence and prevalence in Alberta between 1995 and 2015
por: Bosonea, Ana-Maria, et al.
Publicado: (2020)

Epidemiology of pertussis in Alberta, Canada 2004–2015
por: Liu, Xianfang C., et al.
Publicado: (2017)

Economic Evaluations of Digital Health Interventions for the Management of Musculoskeletal Disorders: Systematic Review and Meta-Analysis
por: Fatoye, Francis, et al.
Publicado: (2023)

Coping with systemic lupus erythematosus in patients’ words
por: Cornet, Alain, et al.
Publicado: (2022)

Real-world burden of systemic lupus erythematosus in the USA: a comparative cohort study from the Medical Expenditure Panel Survey (MEPS) 2016–2018
por: Grabich, Shannon, et al.
Publicado: (2022)

Characterisation of concurrent use of prescription opioids and benzodiazepine/Z-drugs in Alberta, Canada: a population-based study
por: Sharma, Vishal, et al.
Publicado: (2019)

Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA
por: Bell, Christopher F, et al.
Publicado: (2020)

Herpes zoster vaccine (HZV): utilization and coverage 2009 – 2013, Alberta, Canada
por: Liu, Xianfang C, et al.
Publicado: (2014)

Clinical and economic burden of low back pain in low- and middle-income countries: a systematic review
por: Fatoye, Francis, et al.
Publicado: (2023)

Clinical and histopathological features of myositis in systemic lupus erythematosus
por: Tiniakou, Eleni, et al.
Publicado: (2022)

Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004–2015
por: Hammond, Edward R, et al.
Publicado: (2021)

Concurrent use of opioids and benzodiazepines/Z-drugs in Alberta, Canada and the risk of hospitalisation and death: a case cross-over study
por: Sharma, Vishal, et al.
Publicado: (2020)

Economic Impact of COVID-19 lockdown on households
por: Fatoye, Francis, et al.
Publicado: (2021)

Causes and outcome of hospitalisations in Tunisian patients with systemic lupus erythematosus
por: Jallouli, M, et al.
Publicado: (2014)

Off-label use of rituximab for systemic lupus erythematosus in Europe
por: Rydén-Aulin, Monica, et al.
Publicado: (2016)

Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations
por: Meyer, Aurore, et al.
Publicado: (2020)

Development of a systemic lupus erythematosus cardiovascular risk equation
por: Petri, Michelle A, et al.
Publicado: (2019)

Association of patient copayment and medication adherence in systemic lupus erythematosus
por: Lomanto Silva, Raisa, et al.
Publicado: (2023)

Disease and economic burden increase with systemic lupus erythematosus severity 1 year before and after diagnosis: a real-world cohort study, United States, 2004–2015
por: Jiang, Miao, et al.
Publicado: (2021)

Safe opioid prescribing: a prognostic machine learning approach to predicting 30-day risk after an opioid dispensation in Alberta, Canada
por: Sharma, Vishal, et al.
Publicado: (2021)

Incidence of myeloproliferative neoplasms in Calgary, Alberta, Canada
por: Heppner, Jonathan, et al.
Publicado: (2019)

Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis
por: Murimi-Worstell, Irene B, et al.
Publicado: (2020)

Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus
por: Carli, L, et al.
Publicado: (2016)

Complement levels and risk of organ involvement in patients with systemic lupus erythematosus
por: Gandino, Ignacio Javier, et al.
Publicado: (2017)

Serum uric acid is associated with damage in patients with systemic lupus erythematosus
por: Elera-Fitzcarrald, Claudia, et al.
Publicado: (2020)

Living with systemic lupus erythematosus in 2020: a European patient survey
por: Cornet, Alain, et al.
Publicado: (2021)

Global and regional estimates of clinical and economic burden of low back pain in high-income countries: a systematic review and meta-analysis
por: Fatoye, Francis, et al.
Publicado: (2023)

The impact of COVID-19 related lockdown restrictions on musculoskeletal health: a systematic review
por: Gebrye, Tadesse, et al.
Publicado: (2023)

Belimumab: a technological advance for systemic lupus erythematosus patients? Report of a systematic review and meta-analysis
por: Kandala, Ngianga-Bakwin, et al.
Publicado: (2013)

Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population study
por: Jiang, Xiaofeng, et al.
Publicado: (2023)

Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus Registry
por: Plantinga, Laura C, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jqjdlohs4u6pf2e0sc0utdl0d2